期刊文献+

灭活贝氏柯克斯体免疫小鼠抗登革病毒感染的实验研究

Efficacy of inactivated Coxiella burnetii against dengue virus infection in mice
下载PDF
导出
摘要 目的研究灭活贝氏柯克斯体增强小鼠非特异性抗登革病毒感染的免疫效能。方法用灭活贝氏柯克斯体全细胞疫苗(WCV)免疫BALB/c小鼠,每只小鼠皮下注射50μgWCV,初次免疫后第5周及第7周分别腹腔注射20μg WCV加强免疫。1周后,用10^5 TCID50剂量的登革病毒2型经尾静脉注入感染小鼠,于感染后48、72h分别解剖小鼠,自血和脑组织提取RNA样本,用实时荧光定量聚合酶链反应(PCR)检测样本。结果用登革病毒特异的定量PCR检测感染小鼠血RNA样本,结果显示感染72h血样本中病毒含量显著低于48h样本,但免疫小鼠与未免疫小鼠之间无显著差异。检测脑组织RNA样本,未免疫小鼠和免疫小鼠的感染48h样本检出病毒均为少量;但未免疫小鼠感染96h样本检出病毒量明显增加,显著高于免疫小鼠。结论灭活贝氏柯克斯体可诱导机体产生非特异的免疫应答,具有一定增强小鼠抗登革病毒感染的能力,但具体机制有待进一步研究。 Objective To assess the efficacy of the Q fever vaccine against dengue virus infection. Methods The inactivated Coxiella burnerii (whole cell vaccine, WCV) was used to immunize BALB/c mice. For primary immunization, 50Vg WCV per monse was subcutaneously injected and 20μg WCV per mouse was intraperitoneally injected at Weeks 5 and 7 after primary immunization, respectively. One week after the last immunization, each mouse was challenged with 10s TCID50 of dengue virus via administration through the tail vein. The mice were sacrificed and blood and brain samples were collected 48 or 72 h after viral challenge. Samples were then examined by real-time quantitative PCR specific to dengue virus. Results In real-time quantitative PCR assay of blood samples, the amount of virus 72h postinfection was significantly lower than that observed at 48h and no significant difference was found between immunized mice and non-immunized mice. The amount of virus in brain samples from both non-immunized and immunized mice at 48h post infection was very low, however the amount of virus in brain samples from non-immunized mice rose sharply and was signifieanfly higher than that of immunized mice at 72h postinfection. Conclusion Non-specific immunoresponses against dengue virus infection may be induced by inactivated C. burnetii in mice.
出处 《微生物与感染》 2007年第4期211-214,共4页 Journal of Microbes and Infections
基金 国家863计划项目(2006AA02Z459)资助
关键词 贝氏柯克斯体 登革病毒 非特异性免疫 Coxiella burnetii dengue virus nonspecific immunity
  • 相关文献

参考文献13

  • 1Waag DM,Kende M,Damrow TA,et al.Injection of inactivated phase I Coxiella bumetii increases non-specific resistance to infection and stimulates lymphokine production in mice.Ann N Y Acad Sci,1990,590:203-214
  • 2Zvilich M,Williams JC,Waag D,et al.Efficacy of Coxiella bumetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus Infectioninmice.Antiviral Res, 19915,27:137-149
  • 3Krieg AM,Yi AK,Matson S,et al.CoG motifs in bacterial DNA trigger direct B-cell activation.Nature,1995,374:546-549
  • 4孙长俭,陈梅玲,温博海,刘海洪,杨晓,牛东升.两种Q热疫苗的脂肪酸分析[J].中国人兽共患病学报,2006,22(11):1009-1012. 被引量:5
  • 5孙长俭,陈梅玲,杨晓,温博海,牛东升,李青凤,王锡乐.氯仿-甲醇提取贝氏柯克斯体残存组分Q热疫苗的免疫原性及免疫保护性研究[J].中国人兽共患病学报,2007,23(6):544-547. 被引量:6
  • 6Malavige GE,Ranatunga PK,Jayaratne SD,et al.Dengue viral infectition as a cause of encephalopathy.Indian J Med Microbiol,2007,25:143-145
  • 7Chaturvedi UC,Dhawan R,Khanna M,et al.Breakdown of the blood-brain during dengue virus infection of mice.J Gene Virol,199l,72:859-866
  • 8Williams JM, Cantrell JL.Biological and immunological properties of Coxiella bumetii vaccines in C57BL/10ScN endotoxin nonresponder mice.Infect Immun,1982,35:1091-1102
  • 9Kelly MT.Activation of guinea pig macrophages by Q-fever rickettsia.Cell Immunol,1977,28:198-205
  • 10Clark IA,Alleva LM,Mills AC,et al.Resistance to Babesia spp.and Plasmodium sp.in mice pretreated with an extract of Coxiella bumetii.Infect Immun,1979,24:319-325

二级参考文献21

  • 1孙长俭,陈梅玲,温博海,刘海洪,杨晓,牛东升.两种Q热疫苗的脂肪酸分析[J].中国人兽共患病学报,2006,22(11):1009-1012. 被引量:5
  • 2顾方舟.病毒、立克次体及衣原体疾病诊断技术[M].北京:北京医科大学 中国协和医科大学联合出版社,1993.591-598.
  • 3Wagg DM,England MJ,Tammariello RF,et al.Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol[J].Vaccine,2002,20:2623 -2634.
  • 4Beckman EM,Porcelli SA,Morita CT.Recognition of a lipid antigen by CD1-restricted αβ+T cells[J].Nature,1994,372:691-694.
  • 5Williams JM,Peacock MG,McFaul TF.Immunological and biological characterization of Coxiella burnetii,Phases Ⅰ and Ⅱ,Separated from Host Components[J].Infect immun,1981,32:840-851.
  • 6Williams JM,Cantrell JL.Biological and immunological properties of Coxiella burnetii vaccines in C57BL /1OScN endotoxinnonresponder Mice[J].Infect immun,1982,35:1091-1102.
  • 7Wen B,Yu SR,Yu GQ,et al.Analysis of proteins and lipopolysaccharide from Chinese isolates of Coxiella burnetii with monoclonal antibodies[J].Acta Virol,1991,35:538-544.
  • 8Luoto L,Bell JF,Casey M,et al.Q fever vaccination of human volunteers I.The serologic and skin test responses following subcutaneous injections[J].Am J Hyg,1963,28:1-15.
  • 9Moody DB,Porcelli SA.Intracellular pathways of CD1 antigen presentation[J].Nature reviews (immunology),2002,3:11-22.
  • 10Moody DB,Zajonc DM.Anatomy of CD1 lipid antigen complexes[J].Nature Reviews (Immunology),2005,5:387-399.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部